Boone Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-360,764
Closed -$26.4M 13
2025
Q1
$26.4M Sell
360,764
-207,701
-37% -$17.2M 8.99% 4
2024
Q4
$47M Sell
568,465
-83,245
-13% -$6.57M 15.86% 2
2024
Q3
$46.6M Buy
651,710
+14,395
+2% +$1.02M 12.09% 2
2024
Q2
$43.6M Buy
637,315
+107,490
+20% +$6.42M 11.38% 2
2024
Q1
$28.4M Hold
529,825
5.75% 6
2023
Q4
$28.2M Buy
529,825
+101,373
+24% +$4.94M 6.59% 5
2023
Q3
$21.3M Buy
+428,452
New +$24M 6.71% 8

Other funds holding GMED

Boone Capital Management's GMED Position: Q2 2025 in Review

Boone Capital Management sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 360,764 shares — an estimated $26.4M sold.

Boone Capital Management first reported a position in GMED in Q3 2023 and held it in 7 quarters. The position peaked at $47M in Q4 2024. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Boone Capital Management reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Boone Capital Management sold 360,764 Globus Medical shares in Q2 2025, an estimated $26.4M.
  • Boone Capital Management first reported a position in Globus Medical in Q3 2023 and held it in 7 quarters.
  • Boone Capital Management's Globus Medical position peaked at $47M in Q4 2024.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Boone Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.